Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology-Reference-Cited by-同舟云学术

Preservation of neutralizing antibody function in COVID‐19 convalescent plasma treated using a riboflavin and ultraviolet light‐based pathogen reduction technology

Published:2021-04-09 Issue:10 Volume:116 Page:1076-1083
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Yonemura Susan¹^ORCID,Hartson Lindsay²^ORCID,Dutt Taru S.³^ORCID,Henao‐Tamayo Marcela³^ORCID,Goodrich Raymond²^ORCID,Marschner Susanne¹^ORCID

Affiliation:

1. Terumo Blood and Cell Technologies Lakewood CO USA

2. Infectious Disease Research Center Colorado State University Fort Collins CO USA

3. Department of Microbiology, Immunology & Pathology Colorado State University Fort Collins CO USA

Funder

Terumo BCT

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.13108

Reference40 articles.

1. Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?

2. Treatment of severe acute respiratory syndrome with convalescent plasma;Wong VW;Hong Kong Med J,2003

3. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital

4. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience

5. Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-05

2. Persistent CD8+ T cell proliferation and activation in COVID-19 adult survivors with post-acute sequelae: a longitudinal, observational cohort study of persistent symptoms and T cell markers;Frontiers in Immunology;2024-01-23

3. Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics;Journal of Pharmaceutical Sciences;2023-11

4. Emerging Pathogen Threats in Transfusion Medicine: Improving Safety and Confidence with Pathogen Reduction Technologies;Pathogens;2023-07-05

5. The Impact of Pathogen Reduction on Total IgG and IgG Subclass Profiles of Convalescent Plasma;Transfusion Medicine and Hemotherapy;2023-06-21